CRP and breast carcinoma: Even if previous data suggest the tumoricidal activity of mCRP and its potential induction in leukemia cell lines in vitro, there exists a study elucidating the critical link between CRP, integrin α2, and FcγRI pathways in MCF10A breast cells and MDA-MB-231 triple-negative human breast cancer cells, thus providing useful evidence on the CRP-induced aggressiveness of breast cells in inflammatory microenvironments [156].